Med Center 'Ok!Clinic+' of International Institute of Clinical Trials LLC

Kyiv 2091

1 studies enrolling now · 3 studies all time

What they study most

Dyslipidemia, Mature B-cell Malignancies, Rheumatoid Arthritis, Type2 Diabetes

Studies at this site

• Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell Malignancies — Recruiting now
• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis — Completed